The weed killer, Roundup has been one of the best-selling agricultural and gardening products in the U.S. for several decades. Its main ingredient, glyphosate, has been linked to certain types of cancer, particularly non-Hodgkin’s lymphoma.
The cancer link was denied for years by Roundup’s manufacturer, Monsanto until internal documents were unsealed in 2017, after a number of Roundup lawsuits had been filed. The documents included internal emails indicating that Monsanto had known about the potential link to cancer and had taken great steps to keep the knowledge from becoming public.
In 2018, Monsanto was acquired by German chemical and pharmaceutical giant, Bayer. The World Health Organization (WHO) had already declared that Roundup’s main ingredient, glyphosate is a probable carcinogen and Bayer is now facing more than 42,000 Roundup Weed Killer Lawsuits, a number that has more than doubled since mid-July 2019.
First Roundup Lawsuits Go to Trial
In November of 2018, a California jury decided against Monsanto in the case of Dewayne Johnson who claimed that large volumes of Roundup used in his work as a groundkeeper had caused his non-Hodgkin’s lymphoma. The jury awarded Johnson $39 million in compensatory damages and $250 million in punitive damages for a whopping $289 million. The total award was later reduced to $78 million due to limitations on punitive damages already in existence.
In March 2019, in the first Federal Roundup Weedkiller lawsuit trial, a federal jury awarded $80 million to a man who claimed that his non-Hodgkin’s lymphoma cancer had been caused by use of glyphosate-based Roundup at his job as a landscaper. His case was considered to be a bellwether trial, indicating possible future action on more than 700 cases that had already been consolidated in San Francisco federal court.
After 4 weeks of trial, the San Francisco U.S. District Court jury awarded 70-year old Edwin Hardeman $5 million in compensatory damages and $75 million in punitive damages. The total amount was later reduced to comply with a limit on punitive to actual damages, which reduced the award to $25.27 million.
Growing Numbers of Roundup Weed Killer Lawsuits
Over 42,000 people or their loved ones have already filed or joined lawsuits against Bayer, parent company of Monsanto. The glyphosate-based weed killer Roundup is being blamed for cancer, mainly non-Hodgkin’s lymphoma (NHL) but also for other attacks on the gastrointestinal system including celiac disease.
Germany, where Roundup’s manufacturer, Bayer is headquartered, will block sales of Roundup or any glyphosate-based weed killer starting in 2023 and other countries may follow suit.
Bayer Roundup Weed Killer Lawsuit Settlement
The number of current Roundup lawsuits, 42,700, is more than double the number, 18,400, that was reported by Bayer in mid-July 2019 and cases continue to be filed. Bayer’s share price has dropped by more than 30% thus far and the company faces looming trials in federal and state courts in California, Missouri, Montana, Hawaii, Nebraska, Illinois and North Carolina. In addition to groundskeepers, some of the new cases involve farmers and other users of Roundup.
Though the company has lost its first two court cases for Roundup cancer lawsuits, Bayer has not indicated that they are close to reaching a settlement. Some news agencies have reported that the company floated a $6 to $8 billion value for estimated settlement totals, but others have dismissed the reports and said that they are “fiction”.
Filing a Bayer Roundup Weed Killer Lawsuit Settlement
People or loved ones of those who used Roundup glyphosate Weed Killer and were diagnosed with non-Hodgkin’s lymphoma cancer may be eligible for compensation and should seek legal advice. Medical injury and product liability cases have provided compensation for damages such as medical costs, lost wages, pain and suffering and if the victim has died, wrongful death.